MDXXF
Price
$0.09
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
9.59M
ZIVO
Price
$17.01
Change
-$1.98 (-10.43%)
Updated
Aug 28 closing price
Capitalization
64.93M
Interact to see
Advertisement

MDXXF vs ZIVO

Header iconMDXXF vs ZIVO Comparison
Open Charts MDXXF vs ZIVOBanner chart's image
PharmAla Biotech Holdings
Price$0.09
Change-$0.00 (-0.00%)
Volume$600
Capitalization9.59M
Zivo Bioscience
Price$17.01
Change-$1.98 (-10.43%)
Volume$283
Capitalization64.93M
MDXXF vs ZIVO Comparison Chart in %
Loading...
MDXXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZIVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDXXF vs. ZIVO commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDXXF is a Buy and ZIVO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (MDXXF: $0.09 vs. ZIVO: $17.01)
Brand notoriety: MDXXF and ZIVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDXXF: 2% vs. ZIVO: 26%
Market capitalization -- MDXXF: $9.59M vs. ZIVO: $64.93M
MDXXF [@Biotechnology] is valued at $9.59M. ZIVO’s [@Biotechnology] market capitalization is $64.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDXXF’s FA Score shows that 0 FA rating(s) are green whileZIVO’s FA Score has 0 green FA rating(s).

  • MDXXF’s FA Score: 0 green, 5 red.
  • ZIVO’s FA Score: 0 green, 5 red.
According to our system of comparison, MDXXF is a better buy in the long-term than ZIVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDXXF’s TA Score shows that 6 TA indicator(s) are bullish while ZIVO’s TA Score has 4 bullish TA indicator(s).

  • MDXXF’s TA Score: 6 bullish, 4 bearish.
  • ZIVO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, MDXXF is a better buy in the short-term than ZIVO.

Price Growth

MDXXF (@Biotechnology) experienced а -2.25% price change this week, while ZIVO (@Biotechnology) price change was -1.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.07%, and the average quarterly price growth was +29.15%.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZIVO($64.9M) has a higher market cap than MDXXF($9.59M). ZIVO YTD gains are higher at: -20.884 vs. MDXXF (-47.775). MDXXF has higher annual earnings (EBITDA): -1.86M vs. ZIVO (-9.7M). MDXXF has more cash in the bank: 1.25M vs. ZIVO (9.82K). MDXXF has higher revenues than ZIVO: MDXXF (421K) vs ZIVO (175K).
MDXXFZIVOMDXXF / ZIVO
Capitalization9.59M64.9M15%
EBITDA-1.86M-9.7M19%
Gain YTD-47.775-20.884229%
P/E RatioN/AN/A-
Revenue421K175K241%
Total Cash1.25M9.82K12,674%
Total DebtN/A779K-
FUNDAMENTALS RATINGS
ZIVO: Fundamental Ratings
ZIVO
OUTLOOK RATING
1..100
90
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MDXXFZIVO
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 24 days ago
82%
Bullish Trend 12 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MDXXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZIVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSX32.660.12
+0.37%
CSX Corp
TDAC10.340.01
+0.05%
Translational Development Acquisition Corp.
GVA109.92-0.05
-0.05%
Granite Construction
CGBD13.81-0.04
-0.29%
Carlyle Secured Lending
MSAI0.72-0.01
-1.12%
MultiSensor AI Holdings

MDXXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXXF has been loosely correlated with NICXF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXXF jumps, then NICXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXXF
1D Price
Change %
MDXXF100%
-0.94%
NICXF - MDXXF
46%
Loosely correlated
N/A
ABVC - MDXXF
25%
Poorly correlated
+3.36%
ZIVO - MDXXF
23%
Poorly correlated
-10.43%
KNSA - MDXXF
20%
Poorly correlated
-0.59%
VYGR - MDXXF
20%
Poorly correlated
-0.58%
More

ZIVO and

Correlation & Price change

A.I.dvisor tells us that ZIVO and APLM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZIVO and APLM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZIVO
1D Price
Change %
ZIVO100%
-10.43%
APLM - ZIVO
28%
Poorly correlated
-32.83%
LGVN - ZIVO
24%
Poorly correlated
+1.02%
MDXXF - ZIVO
24%
Poorly correlated
-0.94%
AKRO - ZIVO
23%
Poorly correlated
-2.59%
ATOS - ZIVO
23%
Poorly correlated
-0.97%
More